I have considerable litigation (trial and appellate) experience, particularly in relation to multi-jurisdictional patent disputes, interlocutory disputes, the analysis of patent infringement and validity and in the preparation of evidence with expert witnesses.

I have acted in numerous advisory and contentious trade mark, copyright and consumer law disputes. I am also an experienced commercial lawyer with front-end experience drafting and negotiating commercialisation agreements, IP licences and confidentiality agreements.

In addition to my legal qualifications, I have a Bachelor of Science, majoring in Pharmacology and Biochemistry & Molecular Biology, and a Masters in Intellectual Property Law. My technical background is invaluable in my development of commercial and litigation strategies and in my dealings with clients and expert witnesses. It equips me with an intellectual curiosity and drive to understand and realise clients' commercial objectives.

I am a member of the Victorian Committee of the Intellectual Property Society of Australia & New Zealand (IPSANZ).

Career highlights

• Ono Pharmaceutical: Acted for Ono Pharmaceutical and a subsidiary of Bristol-Myers Squibb in patent litigation regarding breakthrough antibodies that are of significant use in cancer treatment.
• B Braun: Acted for B Braun in its defence of patent infringement allegations concerning a wound debridement pad.
• Acted in interlocutory injunction applications and substantive patent infringement and invalidity litigation across a range of industries and sectors.
• Regularly advise pharmaceutical and biopharmaceutical clients on the enforcement of their patent portfolios in Australia, and in relation to launch strategies for biologics and biosimilar products, small molecules and medical devices.
• Acted in a number of trade mark and consumer law disputes, and advise global and domestic brands in relation to trade mark protection and brand strategies, both offensively and defensively.

• Commonwealth loses appeal in its $325m Pharmaceutical Benefits Scheme compensation claim
  

  We explore the implications of the Full Court decision in the Commonwealth's damages claim against Sanofi for enforcing an invalid patent.